Trailing-twelve-month (TTM) revenue is $98.65 Million with a year-over-year growth of (5.82%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $26,067,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-07 |
| Q4 FY2025Period ended 2025-12-31 | $32,239,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-12 |
| Q1 FY2026Period ended 2026-03-31 | $19,844,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-13 |
| Q2 FY2026Period ended 2026-06-30 | $20,504,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-13 |
| TTM revenue | $98,654,000 |
Current P/S: $165,581,145 market capitalization ÷ $98,654,000 TTM revenue = 1.68x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T16:15:13.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $20.50M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T16:18:11.977Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20252025-12-31 · USD |
|---|---|
| Other Revenue | $215,000 |
$98.65M
$98.65 Million
(5.82%)
vs. $104.75M a year ago (TTM)
+13.75%
5 Year compound annual growth rate
1 Year
(5.82%)
3 Year
+17.02%
5 Year
+13.75%
10 Year
+29.05%
15 Year
+39.81%
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $109.43M | +$17.30M | +18.78% |
| 2024 | $92.13M | +$20.61M | +28.81% |
| 2023 | $71.52M | +$9.07M | +14.53% |
| 2022 | $62.45M | +$1.16M | +1.89% |
| 2021 | $61.29M | +$17.98M | +41.51% |
| 2020 |
TTM Growth
(5.82%)
3-Year CAGR
+17.02%
5-Year CAGR
+13.75%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T16:18:11.977Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| $43.31M |
| +$18.72M |
| +76.08% |
| 2019 | $24.60M | +$3.39M | +15.99% |
| 2018 | $21.21M | +$9.08M | +74.86% |
| 2017 | $12.13M | +$4.38M | +56.45% |
| 2016 | $7.75M | +$530,784 | +7.35% |
